These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Clinical trial of a new oral antidiabetic: glypizide]. Paes E; Gomes FJ; Pinto RE; De Alburquerque MA; Farinha H Rev Iber Endocrinol; 1974; 21(125):459-62, 466-6, 469-70 passim. PubMed ID: 4422452 [No Abstract] [Full Text] [Related]
5. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide]. Birk W; Petrides P Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033 [No Abstract] [Full Text] [Related]
6. [The therapeutic value of combined treatment with biguanides and sulfonylurea preparations in the presence of resistance to sulfanilamide drugs in diabetes mellitus patients]. Penchev I; Andreev D; Popov A; Pampulov L Probl Endokrinol (Mosk); 1970; 16(6):3-7. PubMed ID: 5521087 [No Abstract] [Full Text] [Related]
7. Insulin, glucose and lipid levels in mild diabetics in relation to complications. Fraser R; Lowy C; Elkeles RS; Lewis B; Mancini M Adv Metab Disord; 1973; 2():Suppl 2:83-101. PubMed ID: 4720391 [No Abstract] [Full Text] [Related]
8. Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563. Berchtold P; Björntorp P; Gustafson A; Jonsson A; Fagerberg SE Eur J Clin Pharmacol; 1971 Dec; 4(1):22-8. PubMed ID: 5151389 [No Abstract] [Full Text] [Related]
10. [On the clinical use of biguanides]. Haese E Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164 [No Abstract] [Full Text] [Related]
11. [Evidence of a reduction of insulin secretion in diabetes with or without obesity. Discussion of the therapeutic use of biguanides]. Luyckx A; Lefebvre P Ann Endocrinol (Paris); 1969; 30(6):717-30. PubMed ID: 5384987 [No Abstract] [Full Text] [Related]
12. [Hypoglycemic effect of glipizide. Study in 20 diabetic patients with low pancreatic insulin reserve]. Laviada E; Camara M Prensa Med Mex; 1973; 38(7):297-302. PubMed ID: 4596814 [No Abstract] [Full Text] [Related]
13. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus]. Ninni M; Castelletta L Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364 [No Abstract] [Full Text] [Related]
14. [Changes in fatty tissue sensitivity to insulin in the process of diabetes mellitus compensation using sulfanilurea derivatives]. Volkova EA; Iaroshevskiĭ IuA Probl Endokrinol (Mosk); 1983; 29(3):13-7. PubMed ID: 6346316 [TBL] [Abstract][Full Text] [Related]
15. [On the indication and practical use of oral antidiabetics]. Fankhauser S Schweiz Med Wochenschr; 1972 Jun; 102(24):856-62. PubMed ID: 5033624 [No Abstract] [Full Text] [Related]
16. [Regadrin treatment of diabetes mellitus]. Hohlfeld R; Neugebauer A; Haaser B; Marek H; Reuter W Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:154-6. PubMed ID: 4734038 [No Abstract] [Full Text] [Related]
17. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus. Fövényi J Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874 [No Abstract] [Full Text] [Related]
18. [Long term efficacy and tolerance of antidiabetic treatments. New data]. Mirouze J Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493 [No Abstract] [Full Text] [Related]
19. [Diabetes: new drugs?]. Codaccioni JL; Fontaine G Sem Hop; 1976 May; 52(20):1243-5. PubMed ID: 189407 [No Abstract] [Full Text] [Related]